Anti-ROR2/ BDB/ BDB1 monoclonal antibody

Anti-ROR2/ BDB/ BDB1 antibody for FACS & in-vivo assay

Target products collectionGo to ROR2/ROR2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T91435-Ab-1/ GM-Tg-hg-T91435-Ab-2Anti-Human ROR2 monoclonal antibodyHuman
GM-Tg-rg-T91435-Ab-1/ GM-Tg-rg-T91435-Ab-2Anti-Rat ROR2 monoclonal antibodyRat
GM-Tg-mg-T91435-Ab-1/ GM-Tg-mg-T91435-Ab-2Anti-Mouse ROR2 monoclonal antibodyMouse
GM-Tg-cynog-T91435-Ab-1/ GM-Tg-cynog-T91435-Ab-2Anti-Cynomolgus/ Rhesus macaque ROR2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T91435-Ab-1/ GM-Tg-felg-T91435-Ab-2Anti-Feline ROR2 monoclonal antibodyFeline
GM-Tg-cang-T91435-Ab-1/ GM-Tg-cang-T91435-Ab-2Anti-Canine ROR2 monoclonal antibodyCanine
GM-Tg-bovg-T91435-Ab-1/ GM-Tg-bovg-T91435-Ab-2Anti-Bovine ROR2 monoclonal antibodyBovine
GM-Tg-equg-T91435-Ab-1/ GM-Tg-equg-T91435-Ab-2Anti-Equine ROR2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T91435-Ab-1/ GM-Tg-hg-T91435-Ab-2; GM-Tg-rg-T91435-Ab-1/ GM-Tg-rg-T91435-Ab-2;
GM-Tg-mg-T91435-Ab-1/ GM-Tg-mg-T91435-Ab-2; GM-Tg-cynog-T91435-Ab-1/ GM-Tg-cynog-T91435-Ab-2;
GM-Tg-felg-T91435-Ab-1/ GM-Tg-felg-T91435-Ab-2; GM-Tg-cang-T91435-Ab-1/ GM-Tg-cang-T91435-Ab-2;
GM-Tg-bovg-T91435-Ab-1/ GM-Tg-bovg-T91435-Ab-2; GM-Tg-equg-T91435-Ab-1/ GM-Tg-equg-T91435-Ab-2
Products NameAnti-ROR2 monoclonal antibody
Formatmab
Target NameROR2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ROR2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ROR2/ BDB/ BDB1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAD000584human ROR2 Adenovirus particle
    ORF Viral VectorpGMAD000584human ROR2 Adenovirus plasmid
    ORF Viral VectorpGMLPm004465mouse Ror2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004465mouse Ror2 Lentivirus particle


    Target information

    Target IDGM-T91435
    Target NameROR2
    Gene ID4920,26564,306782,715482,484193,101087689,785924,100064718
    Gene Symbol and SynonymsBDB,BDB1,NTRKR2,ROR2
    Uniprot AccessionQ01974
    Uniprot Entry NameROR2_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000169071
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: ROR2, gene name: ROR2, also named as BDB, BDB1, NTRKR2. The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors.  The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development.  Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.